無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の幹細胞市場の調査と分析

Global Stem Cells Market Research and Forecast 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 425887
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
世界の幹細胞市場の調査と分析 Global Stem Cells Market Research and Forecast 2018-2023
出版日: 2018年09月11日 ページ情報: 英文
概要

当レポートでは、世界の幹細胞市場について調査分析を行い、市場概要、市場動向、競合状況などについて考察するとともに、地域別に市場を分析、企業プロファイルなどについて包括的に分析し、まとめています。

第1章 レポートのサマリー

  • 調査方法とツール
  • 市場概要

第2章 市場概要と考察

  • 定義
  • ギャップ分析
  • 実績分析
  • アナリストによる考察と現在の市場動向
  • 規制
  • 特許分析

第3章 市場決定因子

  • 市場促進因子
  • 市場抑制因子
  • 市場機会

第4章 市場セグメンテーション

  • 製品別
  • 技術別
  • 用途別

第5章 競合状況

  • 市場シェア分析
  • 主要企業分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の諸国

第7章 企業プロファイル

図表

List of Tables

  • TABLE # 1 GLOBAL STEM CELLS MARKET RESEARCH AND FORECAST BY PRODUCTS, 2017-2013 ($ MILLION)
  • TABLE # 2 GLOBAL ADULT STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 3 GLOBAL HEMATOPOIETIC STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 4 GLOBAL MESENCHYMAL STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 5 GLOBAL NEURONAL STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 6 GLOBAL DENTAL STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 7 GLOBAL UMBILICAL CORD STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 8 GLOBAL HUMAN EMBRYONIC STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 9 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 10 GLOBAL RAT NEURAL STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 11 GLOBAL OTHER STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 12 GLOBAL STEM CELL MARKET RESEARCH AND FORECAST BY TECHNOLOGY, 2017-2013 ($ MILLION)
  • TABLE # 13 GLOBAL STEM CELL ACQUISITION MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 14 GLOBAL THERAPEUTIC CLONING FOR STEM CELL MARKET RESEARCH AND FORECAST, 2017-2013 ($ MILLION)
  • TABLE # 15 GLOBAL IVF STEM CELL MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 16 GLOBAL STEM CELL CULTURE MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 17 GLOBAL STEM CELL CRYOPRESERVATION MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 18 GLOBAL STEM CELLS EXPANSION AND SUB-CULTURE MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 19 GLOBAL STEM CELLS MARKET RESEARCH AND FORECAST BY APPLICATION, 2017-2013 ($ MILLION)
  • TABLE # 20 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 21 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 22 GLOBAL NEUROLOGY MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 23 GLOBAL ORTHOPEDICS MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 24 GLOBAL ONCOLOGY MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 25 GLOBAL HEMATOLOGY MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 26 GLOBAL CVD MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 27 GLOBAL INJURIES MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 28 GLOBAL WOUND CARE MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 29 GLOBAL SPINAL CORD INJURY MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 30 GLOBAL OTHER INJURY MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 31 GLOBAL DIABETES MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 32 GLOBAL LIVER DISORDERS MEDICINES MARKET RESEARCH AND FORECAST 2017-2013 ($ MILLION)
  • TABLE # 33 GLOBAL OTHER STEM CELLS REGENERATIVE MEDICINE MARKET RESEARCH AND FORECAST 2017-2013
  • TABLE # 34 NORTH AMERICA STEM CELL MARKET RESEARCH AND FORECAST, BY PRODUCT 2017-2023 ($ MILLION)
  • TABLE # 35 NORTH AMERICA STEM CELL MARKET RESEARCH AND FORECAST, BY TECHNOLOGY 2017-2023 ($ MILLION)
  • TABLE # 36 NORTH AMERICA STEM CELL, MARKET RESEARCH AND FORECAST, BY APPLICATION 2017-2023 ($ MILLION)
  • TABLE # 37 NORTH AMERICA STEM CELL, MARKET RESEARCH AND FORECAST, BY GEOGRAPHY 2017-2023 ($ MILLION)
  • TABLE # 38 EUROPE STEM CELL MARKET RESEARCH AND FORECAST, BY PRODUCT 2017-2023 ($ MILLION)
  • TABLE # 39 EUROPE STEM CELL MARKET RESEARCH AND FORECAST, BY TECHNOLOGY 2017-2023 ($ MILLION)
  • TABLE # 40 EUROPE STEM CELL, MARKET RESEARCH AND FORECAST, BY APPLICATION 2017-2023 ($ MILLION)
  • TABLE # 41 EUROPE STEM CELL, MARKET RESEARCH AND FORECAST, BY GEOGRAPHY 2017-2023 ($ MILLION)
  • TABLE # 42 ASIA PACIFIC STEM CELL MARKET RESEARCH AND FORECAST, BY PRODUCT 2017-2023 ($ MILLION)
  • TABLE # 43 ASIA PACIFIC STEM CELL MARKET RESEARCH AND FORECAST, BY TECHNOLOGY 2017-2023 ($ MILLION)
  • TABLE # 44 ASIA PACIFIC STEM CELL, MARKET RESEARCH AND FORECAST, BY APPLICATION 2017-2023 ($ MILLION)
  • TABLE # 45 ASIA PACIFIC STEM CELL, MARKET RESEARCH AND FORECAST, BY GEOGRAPHY 2017-2023 ($ MILLION)
  • TABLE # 46 REST OF THE WORLD STEM CELL MARKET RESEARCH AND FORECAST BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 47 REST OF THE WORLD STEM CELL MARKET RESEARCH AND FORECAST BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 48 REST OF THE WORLD STEM CELL MARKET RESEARCH AND FORECAST BY APPLICATION, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL STEM CELL MARKET SHARE, BY PRODUCT 2017 & 2023 (IN %)
  • FIGURE # 2 GLOBAL STEM CELL MARKET SHARE, BY TECHNOLOGY 2017 & 2023 (IN %)
  • FIGURE # 3 GLOBAL STEM CELL, MARKET SHARE, BY APPLICATION 2017 & 2023 (IN %)
  • FIGURE # 4 GLOBAL STEM CELL, MARKET SHARE, BY GEOGRAPHY 2017 & 2023 (IN %)
  • FIGURE # 5 NORTH AMERICA STEM CELL MARKET SHARE, 2017-2023($ MILLION)
  • FIGURE # 6 UNITED STATES STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 CANADA STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 EUROPE STEM CELL MARKET SIZE, 2017-2023($ MILLION)
  • FIGURE # 9 UK STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 GERMANY STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 FRANCE STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 ITALY STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 ROE STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 ASIA PACIFIC MARKET SIZE, 2017-2023($ MILLION)
  • FIGURE # 15 CHINA STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 INDIA STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 JAPAN STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 18 REST OF ASIA PACIFIC (ROAPAC) STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 19 REST OF WORLD (ROW) STEM CELL MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: BIOT-0404

Stem cells market is expected to grow at a CAGR of 21.8% during the forecast period (2018-2023). Stem cell are undifferentiated cells which have the capability of multiplying in multiple number of cells. Stem cells market are of two types- adult stem cells and embryonic stem cells. Stem cells are being studied for their unique regenerative properties. They are being used in drug discovery programs to develop new drugs and treatment methods. Stem cell research is also being used to study genetic disorders, birth defects and other growth factors. Stem cell banks are being established which store stem cells and umbilical cord blood containing stem cells. These are used for treating the individual in future. Stem cell banking is gaining popularity amongst modern day parents who opt to store their new-born's cells to prevent any future ailments. Stem cell are being used to treat and diagnose cancer. These cells are significant part of understanding and treating cancer; especially in children.

Stem cell technology is being funded by governments, NGO's and private firms considering the potential it has in changing the shape of healthcare. New gene editing technologies such as CRISPR is also going to boost the stem cell research and market could witness influx of a number of products. The market is segmented on the basis of products, technology and application. Factors that are motivating the market are innovations and development of new products, growing number of stem cell banks and increasing research in paediatrics. Additionally, rising popularity due to increased research specially in the field of oncology is also motivating the market. However, there are some restrain in the stem cell market such as long approval processes and tough clinical trial regulations, high cost of therapeutic applications, and high cost of stem cell research. Due to this, the research and technology development is limited to financial support from governments.

For related reports: Biotechnology industry

Geographically, North America and Europe contribute around 70% in the total stem cell market. North American and European companies get significant support through funding and investment from government and private players. More number of start-ups and universities are also contributing in these regions and creating considerable scope for global stem cell market. These companies are also attracting a lot of investment. Asia Pacific market is expected to grow at a healthy growth rate during the forecast period 2018-2023. Asia Pacific region gets significant contribution from Japan, China, India and South Korea. Considerable R&D exploration, growing investment and improving healthcare infrastructure creates significant scope for stem cell market in APAC region. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

The key players of global stem cell market include StemCells, Inc., U.S. Stem Cell, Inc., Apceth GmbH und Co. KG and Osiris Therapeutics, Inc. Other companies profiled in the report include AlloSource, Inc, BioTime, Inc., Cell Cure Neurosciences Ltd., Mesoblast Ltd, NeoStem Oncology, LLC, Pluristem Therapeutics Inc., Reliance Life Sciences Pvt. Ltd., ReNeuron Group plc and RTI Surgical, Inc. M&A, product expansion, product launch and partnership are the key strategy adopted in the global Stem cell market. Global Stem cell market players are constantly focusing on expansion, product launch, R&D, innovation and technological advancement. Rising competition makes global Stem cell market dynamic and fast growing.

Research methods and tools

The market study of stem cell has been incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include

  • Financial/annual reports of companies involved in the market
  • Forward looking statement of key stem cell market players
  • Authentic Public Databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.
  • Per capita healthcare expenditure
  • Government funding for the research and development activities

The report is intended for global stem cell market players, potential entrants, diagnostic laboratories, healthcare provider, universities for overall market insights. The report provides in-depth analysis on pricing, market size, market determinants and competitive landscape. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis delivering insights into the market for better business decisions.

Market segmentation

  • Global Stem Cells Market Research and Analysis, By product
  • Global Stem Cells Market Research and Analysis, Technology
  • Global Stem Cells Market Research and Analysis, By Application
  • Global Stem Cells Market Research and Analysis, By Region

THE REPORT COVERS

  • Comprehensive research methodology of Global Stem Cell Market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Stem Cell Market.
  • Insights about market determinants which are stimulating the Global Stem Cell Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

CHAPTER 1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS
    • 1.2.4. EXCEPTIONS

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATION
        • 2.3.1.1.1. UNITED STATES
        • 2.3.1.1.2. EUROPEAN UNION
        • 2.3.1.1.3. CHINA
        • 2.3.1.1.4. INDIA

CHAPTER 3. MARKET DETERMINANT

  • 3.1. MOTIVATORS
    • 3.1.1. INNOVATIONS AND DEVELOPMENT OF NEW PRODUCTS
    • 3.1.2. POPULARITY RISING TO DUE TO INCREASED RESEARCH SPECIALLY IN THE FIELD OF ONCOLOGY
    • 3.1.3. GROWING NUMBER OF STEM CELL BANKS
  • 3.2. RESTRAINT
    • 3.2.1. LONG APPROVAL PROCESSES AND TOUGH CLINICAL TRIALS AND REGULATIONS
    • 3.2.2. HIGH COST OF THERAPEUTIC APPLICATIONS
    • 3.2.3. HIGH COST OF STEM CELL RESEARCH AND LIMITED FINANCIAL SUPPORT FROM GOVERNMENTS
  • 3.3. OPPORTUNITY
    • 3.3.1. EMERGING MARKETS ARE EXPECTED TO BOOST STEM CELL MARKET
    • 3.3.2. GROWING RESEARCH IN PAEDIATRICS
    • 3.3.3. GROWING USAGE OF THERAPEUTIC APPLICATION OVER NO THERAPEUTIC APPLICATIONS

CHAPTER 4. MARKET SEGMENTATION

  • 4.1. STEM CELLS BY PRODUCTS
    • 4.1.1. ADULT STEM CELL
      • 4.1.1.1. HEMATOPOIETIC STEM CELL
      • 4.1.1.2. MESENCHYMAL STEM CELL
      • 4.1.1.3. NEURONAL STEM CELL
      • 4.1.1.4. DENTAL STEM CELL
      • 4.1.1.5. UMBILICAL CORD STEM CELL
    • 4.1.2. HUMAN EMBRYONIC STEM CELL
    • 4.1.3. INDUCED PLURIPOTENT STEM CELL
    • 4.1.4. RAT NEURAL STEM CELL
    • 4.1.5. OTHER
  • 4.2. STEM CELL BY TECHNOLOGY
    • 4.2.1. STEM CELL ACQUISITION
      • 4.2.1.1. THERAPEUTIC CLONING FOR STEM CELL
      • 4.2.1.2. IVF STEM CELL
      • 4.2.1.3. STEM CELL CULTURE
    • 4.2.2. STEM CELL CRYOPRESERVATION
    • 4.2.3. STEM CELLS EXPANSION AND SUB-CULTURE
  • 4.3. STEM CELLS BY APPLICATION
    • 4.3.1. DRUG DISCOVERY AND DEVELOPMENT
    • 4.3.2. STEM CELLS REGENERATIVE MEDICINE
      • 4.3.2.1. NEUROLOGY MEDICINES
      • 4.3.2.2. ORTHOPAEDICS MEDICINES
      • 4.3.2.3. ONCOLOGY MEDICINES
      • 4.3.2.4. HAEMATOLOGY MEDICINES
      • 4.3.2.5. CVD MEDICINES
      • 4.3.2.6. INJURIES MEDICINES
      • 4.3.2.7. DIABETES MEDICINES
      • 4.3.2.8. LIVER DISORDERS MEDICINES
      • 4.3.2.9. OTHER STEM CELLS REGENERATIVE MEDICINE

CHAPTER 5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
  • 5.2. KEY COMPANY ANALYSIS

CHAPTER 6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICA
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. UK
    • 6.2.2. GERMANY
    • 6.2.3. FRANCE
    • 6.2.4. ITALY
    • 6.2.5. SPAIN
    • 6.2.6. REST OF EUROPE
  • 6.3. APAC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
    • 6.3.4. REST OF APAC
  • 6.4. REST OF THE WORLD

CHAPTER 7. COMPANY PROFILES

  • 7.1. ALLOSOURCE, INC.
  • 7.2. ANTEROGEN CO., LTD.
  • 7.3. APCETH GMBH UND CO. KG
  • 7.4. BIOTIME, INC.
  • 7.5. CELL CURE NEUROSCIENCES LTD.
  • 7.6. GAMIDA CELL LTD.
  • 7.7. MEDIPOST CO., LTD.
  • 7.8. MESOBLAST LTD
  • 7.9. NEOSTEM ONCOLOGY, LLC
  • 7.10. NEURALSTEM, INC.
  • 7.11. NUVASIVE, INC.
  • 7.12. OCATA THERAPEUTICS, INC.
  • 7.13. ORTHOCYTE CORPORATION
  • 7.14. ORTHOFIX INC.
  • 7.15. OSIRIS THERAPEUTICS, INC.
  • 7.16. PHARMICELL CO., LTD.
  • 7.17. PLURISTEM THERAPEUTICS INC.
  • 7.18. RELIANCE LIFE SCIENCES PVT. LTD.
  • 7.19. RENEURON GROUP PLC
  • 7.20. RTI SURGICAL, INC.
  • 7.21. STEMCELLS, INC.
  • 7.22. STEMPEUTICS RESEARCH PVT. LTD.
  • 7.23. U.S. STEM CELL, INC. (BIOHEART)
Back to Top